{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T23:58:41Z","timestamp":1776211121520,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004791","name":"Shenzhen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004791","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004791","name":"Shenzhen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004791","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.vaccine.2016.01.018","type":"journal-article","created":{"date-parts":[[2016,1,19]],"date-time":"2016-01-19T12:26:44Z","timestamp":1453206404000},"page":"1034-1039","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Comparative immunogenicity of hepatitis B vaccine with different dosages and schedules in healthy young adults in China"],"prefix":"10.1016","volume":"34","author":[{"given":"Zhen-Zi","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Qiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen-Xing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan-Ping","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue-En","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2016.01.018_bib0170","series-title":"Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection","author":"WHO","year":"2015"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2016.01.018_bib0175","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1365-2893.2010.01266.x","article-title":"Epidemiology and prevention of hepatitis B virus infection in China","volume":"17","author":"Lu","year":"2010","journal-title":"J Viral Hepat"},{"issue":"1","key":"10.1016\/j.vaccine.2016.01.018_bib0180","first-page":"98","article-title":"Vaccination against hepatitis B: the Chinese experience","volume":"122","author":"Zhou","year":"2009","journal-title":"Chin Med J (Engl)"},{"issue":"1","key":"10.1016\/j.vaccine.2016.01.018_bib0185","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1086\/599332","article-title":"Evaluation of the impact of hepatitis B vaccination among children born during 1992\u22122005 in China","volume":"200","author":"Liang","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.01.018_bib0190","unstructured":"National HBV Serosurvey for Chinese population aged 1\u201329 years. China Medical Tribune. August 06, 2015; Sect D-01."},{"issue":"47","key":"10.1016\/j.vaccine.2016.01.018_bib0195","doi-asserted-by":"crossref","first-page":"6550","DOI":"10.1016\/j.vaccine.2009.08.048","article-title":"Epidemiological serosurvey of hepatitis B in China-declining HBV prevalence due to hepatitis B vaccination","volume":"27","author":"Liang","year":"2009","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2016.01.018_bib0200","first-page":"1199","article-title":"Technical guide for adult hepatitis B immunization in China","volume":"32","author":"Cui","year":"2011","journal-title":"Zhonghua Liuxingbingxue Zazhi (Chinese)"},{"issue":"5","key":"10.1016\/j.vaccine.2016.01.018_bib0205","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.4161\/hv.23827","article-title":"Economic analysis of the first 20 years of universal hepatitis B vaccination program in Italy: an a posteriori evaluation and forecast of future benefits","volume":"9","author":"Boccalini","year":"2013","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2016.01.018_bib0210","unstructured":"National Health and Family Planning Commission of the People's Republic of China (NHFPC of the PRC). Operation Standards of Vaccination (2013 Version). Beijing: NHFPC; 2013."},{"key":"10.1016\/j.vaccine.2016.01.018_bib0215","unstructured":"China foundation for hepatitis prevention and control (CFFH). A investigation report on the current status of prevention and control of hepatitis B among college students in China. Beijing: CFFH; 2009."},{"issue":"1","key":"10.1016\/j.vaccine.2016.01.018_bib0220","first-page":"179","article-title":"Immune response to hepatitis B vaccine in health-care workers","volume":"22","author":"Zamani","year":"2011","journal-title":"Saudi J Kidney Dis Transpl"},{"issue":"29","key":"10.1016\/j.vaccine.2016.01.018_bib0225","doi-asserted-by":"crossref","first-page":"3706","DOI":"10.1016\/j.vaccine.2014.02.094","article-title":"Immune response to hepatitis B vaccine with high antigen content in non-responders after standard primary vaccination in Chinese adults","volume":"32","author":"Pan","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.01.018_bib0230","unstructured":"China Food and Drug Administration The standard guidelines for adverse reactions grading in the vaccine clinical trials. <http:\/\/www.sda.gov.cn\/WS01\/CL1036\/9350_5.html> (accessed September 17, 2015)."},{"issue":"1","key":"10.1016\/j.vaccine.2016.01.018_bib0235","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ijid.2007.04.012","article-title":"The underestimated risk of hepatitis A and hepatitis B: benefits of an accelerated vaccination schedule","volume":"12","author":"Keystone","year":"2008","journal-title":"Int J Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2016.01.018_bib0240","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1492-7535.2005.01155.x","article-title":"Antibody response to Engerix-B and Recombivax-HB hepatitis B vaccination in end-stage renal disease","volume":"9","author":"Lacson","year":"2005","journal-title":"Hemodial Int"},{"key":"10.1016\/j.vaccine.2016.01.018_bib0245","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/1471-2369-13-97","article-title":"Association of response to hepatitis B vaccination and survival in dialysis patients","volume":"13","author":"Lin","year":"2012","journal-title":"BMC Nephrol"},{"issue":"22","key":"10.1016\/j.vaccine.2016.01.018_bib0250","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1016\/j.vaccine.2004.11.057","article-title":"Randomized trial of recombinant hepatitis B vaccine in HIV-infected adult patients comparing a standard dose to a double dose","volume":"23","author":"Fonseca","year":"2005","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2016.01.018_bib0255","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1089\/apc.2009.0340","article-title":"Efficacy of double-dose hepatitis B rescue vaccination in HIV-infected patients","volume":"24","author":"Psevdos","year":"2010","journal-title":"AIDS Patient Care STDS"},{"issue":"6","key":"10.1016\/j.vaccine.2016.01.018_bib0260","first-page":"653","article-title":"Study on the Immunogenicity of one dose of 60\u03bcg\/1.0ml Recombinant Yeast Derived Hepatitis B Vaccine (Saccharomyces Cerevisiae) Among Health Population Older than 16 Years","volume":"20","author":"Ma","year":"2013","journal-title":"Shiyong Yufang Yixue (Chinese)"},{"issue":"8682","key":"10.1016\/j.vaccine.2016.01.018_bib0265","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0140-6736(90)90050-F","article-title":"Decline of anti-HBs after hepatitis B vaccination and timing of revaccination","volume":"335","author":"Jilg","year":"1990","journal-title":"Lancet"},{"issue":"8934","key":"10.1016\/j.vaccine.2016.01.018_bib0270","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/S0140-6736(94)90609-2","article-title":"Hepatitis B vaccine boosting among young healthy adults","volume":"344","author":"Tilzey","year":"1994","journal-title":"Lancet"},{"issue":"8400","key":"10.1016\/j.vaccine.2016.01.018_bib0275","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/S0140-6736(84)92926-X","article-title":"Hepatitis B vaccination: how long does protection last?","volume":"2","author":"Jilg","year":"1984","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.vaccine.2016.01.018_bib0280","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1093\/cid\/cir270","article-title":"Hepatitis B and the need for a booster dose","volume":"53","author":"Leuridan","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2016.01.018_bib0285","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.vaccine.2012.10.101","article-title":"Hepatitis B vaccination: a completed schedule enough to control HBV lifelong? Milan, Italy, 17\u201318 November 2011","volume":"31","author":"FitzSimons","year":"2013","journal-title":"Vaccine"},{"issue":"9494","key":"10.1016\/j.vaccine.2016.01.018_bib0290","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/S0140-6736(05)67544-7","article-title":"Hepatitis B vaccination: to boost or not to boost?","volume":"366","author":"Kao","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2016.01.018_bib0295","doi-asserted-by":"crossref","unstructured":"Are booster immunizations needed for lifelong hepatitis B immunity? European Consensus Group on Hepatitis B Immunity. Lancet 2000; 355(9203):561\u22125.","DOI":"10.1016\/S0140-6736(99)07239-6"},{"issue":"8","key":"10.1016\/j.vaccine.2016.01.018_bib0300","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1080\/00365540110080881","article-title":"A 2-dose regimen of a recombinant hepatitis B vaccine with the immune stimulant AS04 compared with the standard 3-dose regimen of Engerix-B in healthy young adults","volume":"34","author":"Levie","year":"2002","journal-title":"Scand J Infect Dis"},{"issue":"11","key":"10.1016\/j.vaccine.2016.01.018_bib0305","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1097\/INF.0b013e3181342887","article-title":"Comparative efficacy of two dosages of recombinant hepatitis B vaccine in healthy adolescents in India","volume":"26","author":"Velu","year":"2007","journal-title":"Pediatr Infect Dis J"},{"issue":"6","key":"10.1016\/j.vaccine.2016.01.018_bib0310","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/S0264-410X(97)00233-8","article-title":"A two-dose hepatitis B vaccine regimen: proof of priming and memory responses in young adults","volume":"16","author":"Marsano","year":"1998","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2016.01.018_bib0315","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1016\/j.vaccine.2009.12.053","article-title":"Antibody persistence six years after two doses of combined hepatitis A and B vaccine","volume":"28","author":"Burgess","year":"2010","journal-title":"Vaccine"},{"issue":"40","key":"10.1016\/j.vaccine.2016.01.018_bib0320","first-page":"405","article-title":"Hepatitis B vaccines: WHO position paper","volume":"84","author":"WHO","year":"2009","journal-title":"Wkly Epidemiol Rec"},{"issue":"6","key":"10.1016\/j.vaccine.2016.01.018_bib0325","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1086\/516485","article-title":"Immunogenicity of two doses of yeast recombinant hepatitis B vaccine in healthy older adults","volume":"175","author":"Gellin","year":"1997","journal-title":"J Infect Dis"},{"issue":"10","key":"10.1016\/j.vaccine.2016.01.018_bib0330","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1002\/jmv.24012","article-title":"Immune memory response induced in vitro by recombinant hepatitis B surface antigen challenge 13-18 years after primary vaccination","volume":"86","author":"Do","year":"2014","journal-title":"J Med Virol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1600044X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1600044X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,15]],"date-time":"2018-09-15T23:52:47Z","timestamp":1537055567000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X1600044X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":33,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["S0264410X1600044X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.01.018","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative immunogenicity of hepatitis B vaccine with different dosages and schedules in healthy young adults in China","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.01.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}